Paul Strijbos

Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials

Laurent Servais, Karl Yen, Maitea Guridi et al. · Journal of Neuromuscular Diseases · 2021 · 79 citations · Full text

Medicine, Rehabilitation Medicine, Functional Movement Assessment +15

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy

Francesco Muntoni, Barry J. Byrne, Hugh J. McMillan et al. · Neurology and Therapy · 2024 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint

Laurent Servais, Paul Strijbos, Margaux Poleur et al. · Scientific Reports · 2024 · 20 citations · Full text

Pharmacy, Pharmacotherapy, Good Clinical Practice +12

Stride Velocity 95 ^th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular Dystrophy

Michael Rabbia, Maitea Guridi Ormazabal, Hannah Staunton et al. · Journal of Neuromuscular Diseases · 2024 · 17 citations · Full text

Medicine, Rehabilitation Medicine, Functional Movement Assessment +14